UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
9126
Artelo Biosciences
ARTL
$1.13M
| $3.14K | ﹤0.01% |
+312
| New | +$8.04K |
2026 Q2
0 quarters
|
|
9127
Jiuzi Holdings
JZXN
$56.1M
| $3.13K | ﹤0.01% |
3,010
-964
| -24% | -$1.08K |
2025 Q1
5 quarters
|
|
9128
Retractable Technologies
RVP
$16.8M
| $3.12K | ﹤0.01% |
4,339
+2,638
| +155% | +$1.79K |
2020 Q1
25 quarters
|
|
9129
United Acquisition Corp I Units
UAC.U
| $3.12K | ﹤0.01% |
306
+127
| +71% | +$1.28K |
2026 Q1
1 quarter
|
|
9130
The9 Ltd
NCTY
$43.1M
| $3.11K | ﹤0.01% |
635
+306
| +93% | +$1.62K |
2024 Q2
8 quarters
|
|
9131
Jaguar Uranium Corp
JAGU
$18.2M
| $3.1K | ﹤0.01% |
1,856
-14,503
| -89% | -$32.1K |
2026 Q1
1 quarter
|
|
9132
LightWave Acquisition Corp Units
LWACU
| $3.08K | ﹤0.01% |
300
| – | – |
2025 Q4
2 quarters
|
|
9133
CervoMed
CRVO
$21.6M
| $3.08K | ﹤0.01% |
992
-4,247
| -81% | -$15K |
2024 Q2
8 quarters
|
|
9134
Innovator 20+ Year Treasury Bond 9 Buffer ETF July
TBJL
$8.64M
| $3.06K | ﹤0.01% |
154
+45
| +41% | +$892 |
2026 Q1
1 quarter
|
|
9135
State Street SPDR Bloomberg Emerging Markets USD Bond ETF
EMHC
$322M
| $3.05K | ﹤0.01% |
+120
| New | +$3.03K |
2026 Q2
0 quarters
|
|
9136
OneIM Acquisition Corp Units
OIMAU
| $3.05K | ﹤0.01% |
300
+200
| +200% | +$2.03K |
2026 Q1
1 quarter
|
|
9137
A SPAC III Acquisition Corp
ASPC
$24M
| $3.04K | ﹤0.01% |
275
-43
| -14% | -$480 |
2026 Q1
1 quarter
|
|
9138
Silynxcom
SYNX
$5.99M
| $3.02K | ﹤0.01% |
2,930
+1,282
| +78% | +$1.48K |
2026 Q1
1 quarter
|
|
9139
Xcel Brands
XELB
$2.79M
| $3.02K | ﹤0.01% |
1,675
+1,197
| +250% | +$2.39K |
2025 Q4
2 quarters
|
|
9140
Eaton Vance High Income Municipal ETF
EVYM
$58.6M
| $3.01K | ﹤0.01% |
59
-64
| -52% | -$3.23K |
2026 Q1
1 quarter
|
|
9141
Abits Group
ABTS
$1.25M
| $3K | ﹤0.01% |
2,588
+2,340
| +944% | +$2.91K |
2024 Q4
6 quarters
|
|
9142
LiveOne
LVO
$36.1M
| $3K | ﹤0.01% |
469
-5,377
| -92% | -$30.4K |
2023 Q4
10 quarters
|
|
9143
Dogwood Therapeutics
DWTX
$45.9M
| $3K | ﹤0.01% |
1,860
-5,225
| -74% | -$8.65K |
2025 Q4
2 quarters
|
|
9144
Reckoner BBB-B CLO ETF
RCLO
$29.7M
| $3K | ﹤0.01% |
+120
| New | +$2.99K |
2026 Q2
0 quarters
|
|
9145
Creative Medical Technology
CELZ
$4.65M
| $2.99K | ﹤0.01% |
2,061
+2,060
| +206,000% | +$4.45K |
2024 Q3
7 quarters
|
|
9146
Pacer ActiveAlpha India Quality ETF
INDQ
$1.04M
| $2.98K | ﹤0.01% |
+114
| New | +$3.02K |
2026 Q2
0 quarters
|
|
9147
Coffee Holding Co
JVA
$29.4M
| $2.97K | ﹤0.01% |
890
-845
| -49% | -$3.58K |
2024 Q2
8 quarters
|
|
9148
PUT
Arqit Quantum
ARQQ
$293M
| $2.97K | ﹤0.01% |
+100
| New | +$1.63K |
2026 Q2
0 quarters
|
|
9149
Nephros
NEPH
$32.6M
| $2.97K | ﹤0.01% |
+831
| New | +$2.7K |
2026 Q2
0 quarters
|
|
9150
ProShares Ultra Copper K-1 Free ETF
UCOP
$4.15M
| $2.97K | ﹤0.01% |
+75
| New | +$3.12K |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.